25 XP   0   0   10

iSpecimen Inc
Buy, Hold or Sell?

Let's analyse Ispecimen together

PenkeI guess you are interested in iSpecimen Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of iSpecimen Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about iSpecimen Inc

I send you an email if I find something interesting about iSpecimen Inc.

Quick analysis of Ispecimen (30 sec.)










What can you expect buying and holding a share of Ispecimen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.07
Expected worth in 1 year
$-0.09
How sure are you?
17.6%

+ What do you gain per year?

Total Gains per Share
$-1.16
Return On Investment
-418.6%

For what price can you sell your share?

Current Price per Share
$0.28
Expected price per share
$0.2 - $0.4151
How sure are you?
50%

1. Valuation of Ispecimen (5 min.)




Live pricePrice per Share (EOD)

$0.28

Intrinsic Value Per Share

$-10.81 - $-12.52

Total Value Per Share

$-9.74 - $-11.45

2. Growth of Ispecimen (5 min.)




Is Ispecimen growing?

Current yearPrevious yearGrowGrow %
How rich?$9.7m$23.9m-$10.1m-73.2%

How much money is Ispecimen making?

Current yearPrevious yearGrowGrow %
Making money-$2.7m-$2.4m-$265.8k-9.7%
Net Profit Margin-122.1%-97.1%--

How much money comes from the company's main activities?

3. Financial Health of Ispecimen (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#104 / 145

Most Revenue
#118 / 145

Most Profit
#83 / 145

Most Efficient
#111 / 145

What can you expect buying and holding a share of Ispecimen? (5 min.)

Welcome investor! Ispecimen's management wants to use your money to grow the business. In return you get a share of Ispecimen.

What can you expect buying and holding a share of Ispecimen?

First you should know what it really means to hold a share of Ispecimen. And how you can make/lose money.

Speculation

The Price per Share of Ispecimen is $0.2778. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ispecimen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ispecimen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.07. Based on the TTM, the Book Value Change Per Share is $-0.29 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.26 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ispecimen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.34-121.7%-0.33-120.3%-0.28-101.5%-0.24-87.1%-0.24-87.1%
Usd Book Value Change Per Share-0.33-117.4%-0.29-104.7%-0.26-93.9%0.0622.7%0.0622.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.33-117.4%-0.29-104.7%-0.26-93.9%0.0622.7%0.0622.7%
Usd Price Per Share0.50-0.97-2.64-2.08-2.08-
Price to Earnings Ratio-0.37--0.71--2.42--2.44--2.44-
Price-to-Total Gains Ratio-1.54--3.42--10.61--1.18--1.18-
Price to Book Ratio0.47-0.62-0.96-1.13-1.13-
Price-to-Total Gains Ratio-1.54--3.42--10.61--1.18--1.18-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.2778
Number of shares3599
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.290.06
Usd Total Gains Per Share-0.290.06
Gains per Quarter (3599 shares)-1,046.35226.93
Gains per Year (3599 shares)-4,185.39907.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4185-41950908898
20-8371-8380018151806
30-12556-12565027232714
40-16742-16750036313622
50-20927-20935045394530
60-25112-25120054465438
70-29298-29305063546346
80-33483-33490072627254
90-37668-37675081708162
100-41854-41860090779070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.017.00.00.0%0.017.00.00.0%0.017.00.00.0%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%3.012.02.017.6%3.012.02.017.6%3.012.02.017.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.017.00.0%0.00.017.00.0%0.00.017.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%3.012.02.017.6%3.012.02.017.6%3.012.02.017.6%

Fundamentals of Ispecimen

About iSpecimen Inc

iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 12:14:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of iSpecimen Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ispecimen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ispecimen to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -119.3% means that $-1.19 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of iSpecimen Inc:

  • The MRQ is -119.3%. The company is making a huge loss. -2
  • The TTM is -122.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-119.3%TTM-122.1%+2.7%
TTM-122.1%YOY-97.1%-25.0%
TTM-122.1%5Y-89.5%-32.6%
5Y-89.5%10Y-89.5%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-119.3%-7.7%-111.6%
TTM-122.1%-6.7%-115.4%
YOY-97.1%2.4%-99.5%
5Y-89.5%-1.5%-88.0%
10Y-89.5%-3.4%-86.1%
1.1.2. Return on Assets

Shows how efficient Ispecimen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ispecimen to the Diagnostics & Research industry mean.
  • -19.4% Return on Assets means that Ispecimen generated $-0.19 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of iSpecimen Inc:

  • The MRQ is -19.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.4%TTM-15.7%-3.7%
TTM-15.7%YOY-8.6%-7.1%
TTM-15.7%5Y-18.1%+2.4%
5Y-18.1%10Y-18.1%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.4%-1.7%-17.7%
TTM-15.7%-1.3%-14.4%
YOY-8.6%-0.9%-7.7%
5Y-18.1%-0.5%-17.6%
10Y-18.1%-0.9%-17.2%
1.1.3. Return on Equity

Shows how efficient Ispecimen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ispecimen to the Diagnostics & Research industry mean.
  • -31.5% Return on Equity means Ispecimen generated $-0.32 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of iSpecimen Inc:

  • The MRQ is -31.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -21.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-31.5%TTM-21.2%-10.4%
TTM-21.2%YOY-10.4%-10.7%
TTM-21.2%5Y-9.4%-11.8%
5Y-9.4%10Y-9.4%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-31.5%-0.7%-30.8%
TTM-21.2%-0.1%-21.1%
YOY-10.4%0.3%-10.7%
5Y-9.4%-1.4%-8.0%
10Y-9.4%-2.3%-7.1%

1.2. Operating Efficiency of iSpecimen Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ispecimen is operating .

  • Measures how much profit Ispecimen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ispecimen to the Diagnostics & Research industry mean.
  • An Operating Margin of -111.5% means the company generated $-1.11  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of iSpecimen Inc:

  • The MRQ is -111.5%. The company is operating very inefficient. -2
  • The TTM is -122.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-111.5%TTM-122.7%+11.2%
TTM-122.7%YOY-99.1%-23.6%
TTM-122.7%5Y-75.4%-47.3%
5Y-75.4%10Y-75.4%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-111.5%-6.2%-105.3%
TTM-122.7%0.5%-123.2%
YOY-99.1%4.3%-103.4%
5Y-75.4%3.7%-79.1%
10Y-75.4%-1.3%-74.1%
1.2.2. Operating Ratio

Measures how efficient Ispecimen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.11 means that the operating costs are $2.11 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of iSpecimen Inc:

  • The MRQ is 2.115. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.240. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.115TTM2.240-0.125
TTM2.240YOY1.991+0.248
TTM2.2405Y1.751+0.488
5Y1.75110Y1.7510.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1151.296+0.819
TTM2.2401.301+0.939
YOY1.9911.238+0.753
5Y1.7511.268+0.483
10Y1.7511.217+0.534

1.3. Liquidity of iSpecimen Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ispecimen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 1.36 means the company has $1.36 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of iSpecimen Inc:

  • The MRQ is 1.362. The company is just able to pay all its short-term debts.
  • The TTM is 2.983. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.362TTM2.983-1.621
TTM2.983YOY10.312-7.329
TTM2.9835Y4.519-1.535
5Y4.51910Y4.5190.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3622.111-0.749
TTM2.9832.298+0.685
YOY10.3122.581+7.731
5Y4.5193.012+1.507
10Y4.5193.081+1.438
1.3.2. Quick Ratio

Measures if Ispecimen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ispecimen to the Diagnostics & Research industry mean.
  • A Quick Ratio of 1.75 means the company can pay off $1.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of iSpecimen Inc:

  • The MRQ is 1.754. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.245. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.754TTM4.245-2.491
TTM4.245YOY10.182-5.937
TTM4.2455Y4.757-0.512
5Y4.75710Y4.7570.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7541.204+0.550
TTM4.2451.285+2.960
YOY10.1821.565+8.617
5Y4.7571.925+2.832
10Y4.7572.128+2.629

1.4. Solvency of iSpecimen Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ispecimen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ispecimen to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.38 means that Ispecimen assets are financed with 38.4% credit (debt) and the remaining percentage (100% - 38.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of iSpecimen Inc:

  • The MRQ is 0.384. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.236. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.384TTM0.236+0.148
TTM0.236YOY0.177+0.058
TTM0.2365Y2.280-2.044
5Y2.28010Y2.2800.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3840.421-0.037
TTM0.2360.407-0.171
YOY0.1770.394-0.217
5Y2.2800.448+1.832
10Y2.2800.446+1.834
1.4.2. Debt to Equity Ratio

Measures if Ispecimen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ispecimen to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 62.4% means that company has $0.62 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of iSpecimen Inc:

  • The MRQ is 0.624. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.329. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.624TTM0.329+0.295
TTM0.329YOY0.216+0.113
TTM0.3295Y0.216+0.113
5Y0.21610Y0.2160.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6240.606+0.018
TTM0.3290.567-0.238
YOY0.2160.631-0.415
5Y0.2160.658-0.442
10Y0.2160.742-0.526

2. Market Valuation of iSpecimen Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ispecimen generates.

  • Above 15 is considered overpriced but always compare Ispecimen to the Diagnostics & Research industry mean.
  • A PE ratio of -0.37 means the investor is paying $-0.37 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of iSpecimen Inc:

  • The EOD is -0.205. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.370. Based on the earnings, the company is expensive. -2
  • The TTM is -0.711. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.205MRQ-0.370+0.165
MRQ-0.370TTM-0.711+0.341
TTM-0.711YOY-2.419+1.708
TTM-0.7115Y-2.439+1.728
5Y-2.43910Y-2.4390.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.205-0.261+0.056
MRQ-0.370-0.409+0.039
TTM-0.711-0.341-0.370
YOY-2.4190.002-2.421
5Y-2.4394.832-7.271
10Y-2.4395.198-7.637
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of iSpecimen Inc:

  • The EOD is -0.918. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.656. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.004. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.918MRQ-1.656+0.738
MRQ-1.656TTM-1.004-0.652
TTM-1.004YOY-3.023+2.018
TTM-1.0045Y-1.999+0.994
5Y-1.99910Y-1.9990.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.918-0.291-0.627
MRQ-1.656-0.441-1.215
TTM-1.004-1.388+0.384
YOY-3.023-2.079-0.944
5Y-1.999-1.446-0.553
10Y-1.999-1.971-0.028
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ispecimen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.47 means the investor is paying $0.47 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of iSpecimen Inc:

  • The EOD is 0.259. Based on the equity, the company is cheap. +2
  • The MRQ is 0.467. Based on the equity, the company is cheap. +2
  • The TTM is 0.617. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.259MRQ0.467-0.208
MRQ0.467TTM0.617-0.150
TTM0.617YOY0.958-0.341
TTM0.6175Y1.130-0.513
5Y1.13010Y1.1300.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.2591.857-1.598
MRQ0.4672.228-1.761
TTM0.6172.222-1.605
YOY0.9583.104-2.146
5Y1.1303.447-2.317
10Y1.1304.036-2.906
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of iSpecimen Inc.

3.1. Institutions holding iSpecimen Inc

Institutions are holding 4.309% of the shares of iSpecimen Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Vanguard Group Inc1.47610134101-16499-10.9555
2023-12-31BlackRock Inc0.624105669900
2023-12-31Geode Capital Management, LLC0.423803849800
2023-12-31Grimes & Company, Inc.0.33920.000530818-25371-45.153
2023-12-31Millennium Management LLC0.2365021488214880
2023-09-30Schonfeld Strategic Advisors LLC0.21460.000119500-700-3.4653
2023-12-31Advisor Group Holdings, Inc.0.1708015516155160
2023-12-31Northern Trust Corp0.15201380500
2023-12-31Renaissance Technologies Corp0.1177010692106920
2023-12-31Main Street Financial Solutions, LLC (PA)0.11560.00071050000
2023-12-31Tower Research Capital LLC0.033803071-46-1.4758
2023-12-31Wells Fargo & Co0.000504125.1282
2023-12-31UBS Group AG0.0001013-91-87.5
2023-12-31Susquehanna International Group, LLP000-22770-100
2023-09-30Citadel Advisors Llc000-23173-100
2023-09-30Claro Advisors LLC000-17305-100
2023-09-30Morgan Stanley - Brokerage Accounts000-8000-100
2023-12-31JPMorgan Chase & Co000-5-100
2023-12-31HRT FINANCIAL LLC000-13380-100
Total 3.90480.0013354742-79642-22.5%

3.2. Funds holding iSpecimen Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv0.9087082576-429-0.5168
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.39603598700
2024-02-29Fidelity Extended Market Index0.331503012300
2023-12-31Northern Trust Extended Eq Market Idx0.07910.0001719200
2023-12-31NT Ext Equity Mkt Idx Fd - L0.07910.0001719200
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07280.0001661300
2024-02-29Fidelity Nasdaq Composite Index0.05870533400
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.05840.00015311100.1886
2024-02-29Fidelity Series Total Market Index0.03350304100
2023-12-31SSgA U.S. Extended Market Index Class I0.0110100000
2024-03-31State St US Extended Mkt Indx NL Cl C0.0110100000
2023-12-31SSgA U.S. Total Market Index Strategy0.00320288-7-2.3729
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00240.000121410.4695
2023-09-30BlackRock Extended Mkt Composite0.0018016100
Total 2.04720.0005186032-425-0.2%

3.3. Insider Transactions

Insiders are holding 33.767% of the shares of iSpecimen Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-09-14Benjamin BielakBUY180000.72
2023-05-31Tracy CurleyBUY44001.25

4. Summary

4.1. Key Performance Indicators

The key performance indicators of iSpecimen Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.326-0.291-11%-0.261-20%0.063-617%0.063-617%
Book Value Per Share--1.0721.520-29%2.633-59%0.331+224%0.331+224%
Current Ratio--1.3622.983-54%10.312-87%4.519-70%4.519-70%
Debt To Asset Ratio--0.3840.236+63%0.177+117%2.280-83%2.280-83%
Debt To Equity Ratio--0.6240.329+90%0.216+189%0.216+189%0.216+189%
Dividend Per Share----0%-0%-0%-0%
Eps---0.338-0.334-1%-0.282-17%-0.242-28%-0.242-28%
Free Cash Flow Per Share---0.076-0.290+284%-0.248+228%-0.219+190%-0.219+190%
Free Cash Flow To Equity Per Share---0.193-0.318+65%-0.342+78%0.231-183%0.231-183%
Gross Profit Margin--1.3201.360-3%1.363-3%1.443-9%1.443-9%
Intrinsic Value_10Y_max---12.523--------
Intrinsic Value_10Y_min---10.812--------
Intrinsic Value_1Y_max---1.164--------
Intrinsic Value_1Y_min---1.143--------
Intrinsic Value_3Y_max---3.567--------
Intrinsic Value_3Y_min---3.404--------
Intrinsic Value_5Y_max---6.053--------
Intrinsic Value_5Y_min---5.612--------
Market Cap2524499.166-80%4552822.4708839836.443-48%24024998.813-81%18886435.445-76%18886435.445-76%
Net Profit Margin---1.193-1.221+2%-0.971-19%-0.895-25%-0.895-25%
Operating Margin---1.115-1.227+10%-0.991-11%-0.754-32%-0.754-32%
Operating Ratio--2.1152.240-6%1.991+6%1.751+21%1.751+21%
Pb Ratio0.259-80%0.4670.617-24%0.958-51%1.130-59%1.130-59%
Pe Ratio-0.205+45%-0.370-0.711+92%-2.419+553%-2.439+559%-2.439+559%
Price Per Share0.278-80%0.5010.973-48%2.644-81%2.078-76%2.078-76%
Price To Free Cash Flow Ratio-0.918+45%-1.656-1.004-39%-3.023+83%-1.999+21%-1.999+21%
Price To Total Gains Ratio-0.852+45%-1.536-3.418+123%-10.615+591%-1.181-23%-1.181-23%
Quick Ratio--1.7544.245-59%10.182-83%4.757-63%4.757-63%
Return On Assets---0.194-0.157-19%-0.086-56%-0.181-7%-0.181-7%
Return On Equity---0.315-0.212-33%-0.104-67%-0.094-70%-0.094-70%
Total Gains Per Share---0.326-0.291-11%-0.261-20%0.063-617%0.063-617%
Usd Book Value--9741077.00013810466.500-29%23924468.500-59%3008892.588+224%3008892.588+224%
Usd Book Value Change Per Share---0.326-0.291-11%-0.261-20%0.063-617%0.063-617%
Usd Book Value Per Share--1.0721.520-29%2.633-59%0.331+224%0.331+224%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.338-0.334-1%-0.282-17%-0.242-28%-0.242-28%
Usd Free Cash Flow---687259.000-2638033.500+284%-2252227.500+228%-1990757.000+190%-1990757.000+190%
Usd Free Cash Flow Per Share---0.076-0.290+284%-0.248+228%-0.219+190%-0.219+190%
Usd Free Cash Flow To Equity Per Share---0.193-0.318+65%-0.342+78%0.231-183%0.231-183%
Usd Market Cap2524499.166-80%4552822.4708839836.443-48%24024998.813-81%18886435.445-76%18886435.445-76%
Usd Price Per Share0.278-80%0.5010.973-48%2.644-81%2.078-76%2.078-76%
Usd Profit---3072961.000-2746335.500-11%-2480475.250-19%-2109989.882-31%-2109989.882-31%
Usd Revenue--2575094.0002482045.500+4%2600575.750-1%2408254.941+7%2408254.941+7%
Usd Total Gains Per Share---0.326-0.291-11%-0.261-20%0.063-617%0.063-617%
 EOD+3 -5MRQTTM+13 -21YOY+8 -265Y+10 -2410Y+10 -24

4.2. Fundamental Score

Let's check the fundamental score of iSpecimen Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.205
Price to Book Ratio (EOD)Between0-10.259
Net Profit Margin (MRQ)Greater than0-1.193
Operating Margin (MRQ)Greater than0-1.115
Quick Ratio (MRQ)Greater than11.754
Current Ratio (MRQ)Greater than11.362
Debt to Asset Ratio (MRQ)Less than10.384
Debt to Equity Ratio (MRQ)Less than10.624
Return on Equity (MRQ)Greater than0.15-0.315
Return on Assets (MRQ)Greater than0.05-0.194
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of iSpecimen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.290
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income Tax Expense  -366252-11489-26-37-63266203



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets15,819
Total Liabilities6,078
Total Stockholder Equity9,741
 As reported
Total Liabilities 6,078
Total Stockholder Equity+ 9,741
Total Assets = 15,819

Assets

Total Assets15,819
Total Current Assets8,239
Long-term Assets7,581
Total Current Assets
Cash And Cash Equivalents 2,344
Short-term Investments 2,662
Net Receivables 2,941
Other Current Assets 292
Total Current Assets  (as reported)8,239
Total Current Assets  (calculated)8,239
+/-0
Long-term Assets
Property Plant Equipment 322
Intangible Assets 7,231
Long-term Assets Other 28
Long-term Assets  (as reported)7,581
Long-term Assets  (calculated)7,581
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities6,049
Long-term Liabilities29
Total Stockholder Equity9,741
Total Current Liabilities
Short-term Debt 167
Accounts payable 3,925
Other Current Liabilities 1,541
Total Current Liabilities  (as reported)6,049
Total Current Liabilities  (calculated)5,633
+/- 416
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt29
Long-term Liabilities  (as reported)29
Long-term Liabilities  (calculated)29
+/- 0
Total Stockholder Equity
Common Stock1
Retained Earnings -59,365
Accumulated Other Comprehensive Income 1
Other Stockholders Equity 69,104
Total Stockholder Equity (as reported)9,741
Total Stockholder Equity (calculated)9,741
+/-0
Other
Capital Stock1
Cash and Short Term Investments 5,006
Common Stock Shares Outstanding 9,083
Current Deferred Revenue416
Liabilities and Stockholders Equity 15,819
Net Debt -2,147
Net Invested Capital 9,741
Net Working Capital 2,190
Property Plant and Equipment Gross 766
Short Long Term Debt Total 196



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
0
4,215
0
0
6,047
6,210
5,824
19,605
17,622
35,720
33,287
30,397
27,940
24,618
21,939
17,570
16,295
15,819
15,81916,29517,57021,93924,61827,94030,39733,28735,72017,62219,6055,8246,2106,047004,2150
   > Total Current Assets 
0
1,581
0
0
3,360
3,472
3,118
16,919
14,899
32,948
30,151
27,131
24,236
19,676
15,960
10,971
9,127
8,239
8,2399,12710,97115,96019,67624,23627,13130,15132,94814,89916,9193,1183,4723,360001,5810
       Cash And Cash Equivalents 
0
54
0
0
957
696
355
13,184
9,791
27,739
26,099
23,691
20,658
15,309
3,763
2,005
2,722
2,344
2,3442,7222,0053,76315,30920,65823,69126,09927,7399,79113,18435569695700540
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,259
6,209
2,941
2,662
2,6622,9416,2097,25900000000000000
       Net Receivables 
0
1,393
0
0
2,262
2,359
2,335
3,292
4,649
4,882
3,756
3,065
3,237
4,067
4,625
2,570
3,143
2,941
2,9413,1432,5704,6254,0673,2373,0653,7564,8824,6493,2922,3352,3592,262001,3930
       Other Current Assets 
0
79
0
0
114
418
428
442
459
327
296
375
342
300
313
188
321
292
29232118831330034237529632745944242841811400790
   > Long-term Assets 
0
2,634
0
0
2,687
2,737
2,706
2,686
2,723
2,771
3,136
3,266
3,704
4,942
5,979
6,599
7,169
7,581
7,5817,1696,5995,9794,9423,7043,2663,1362,7712,7232,6862,7062,7372,687002,6340
       Property Plant Equipment 
0
120
0
0
87
76
64
56
45
33
325
284
242
411
341
271
380
322
322380271341411242284325334556647687001200
       Intangible Assets 
0
2,307
0
0
2,572
2,634
2,613
2,603
2,651
2,711
2,784
2,955
3,434
4,504
5,610
6,300
6,576
7,231
7,2316,5766,3005,6104,5043,4342,9552,7842,7112,6512,6032,6132,6342,572002,3070
       Other Assets 
0
0
0
0
28
28
28
28
28
28
28
28
28
28
0
28
0
0
00280282828282828282828280000
> Total Liabilities 
0
26,933
0
0
31,744
33,488
37,043
8,926
5,531
5,928
5,620
5,100
5,516
4,308
3,855
2,860
3,589
6,078
6,0783,5892,8603,8554,3085,5165,1005,6205,9285,5318,92637,04333,48831,7440026,9330
   > Total Current Liabilities 
0
15,760
0
0
20,261
22,136
25,870
5,926
2,103
2,505
2,047
2,029
2,833
4,281
3,855
2,860
3,517
6,049
6,0493,5172,8603,8554,2812,8332,0292,0472,5052,1035,92625,87022,13620,2610015,7600
       Short-term Debt 
0
10,592
0
0
12,456
12,589
11,412
2,675
0
0
150
619
972
158
147
108
162
167
167162108147158972619150002,67511,41212,58912,4560010,5920
       Short Long Term Debt 
0
0
0
0
12,456
12,589
11,412
0
0
0
0
467
817
0
0
0
0
0
00000817467000011,41212,58912,4560000
       Accounts payable 
0
738
0
0
1,212
1,792
2,092
3,233
351
833
281
433
968
2,459
2,701
1,780
2,280
3,925
3,9252,2801,7802,7012,4599684332818333513,2332,0921,7921,212007380
       Other Current Liabilities 
0
2,214
0
0
6,011
6,881
11,562
1,890
1,033
1,018
1,048
642
239
1,531
908
882
1,028
1,541
1,5411,0288829081,5312396421,0481,0181,0331,89011,5626,8816,011002,2140
   > Long-term Liabilities 
0
11,173
0
0
11,483
11,352
11,173
3,000
3,428
3,423
3,573
3,070
2,683
27
2,946
0
72
29
297202,946272,6833,0703,5733,4233,4283,00011,17311,35211,4830011,1730
       Long term Debt Total 
0
0
0
0
0
0
0
0
3,428
0
0
0
0
0
0
0
0
0
0000000003,42800000000
> Total Stockholder Equity
0
-22,719
0
0
-25,697
-27,278
-31,219
10,679
12,091
29,792
27,667
25,298
22,423
20,309
18,084
14,711
12,706
9,741
9,74112,70614,71118,08420,30922,42325,29827,66729,79212,09110,679-31,219-27,278-25,69700-22,7190
   Common Stock
0
1
0
0
1
0
0
1
1
1
1
1
1
1
1
1
1
1
111111111110010010
   Retained Earnings Total Equity000000000-35,96900000000
   Accumulated Other Comprehensive Income 
0
-217
0
0
-250
-262
-273
-19,605
-17,622
0
0
0
0
0
19
1
1
1
1111900000-17,622-19,605-273-262-25000-2170
   Capital Surplus 
0
0
0
0
0
0
0
0
48,059
0
0
0
0
0
0
0
0
0
00000000048,05900000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
-9,270
0
0
-9,156
-9,132
-9,098
45,095
48,059
67,810
68,070
68,307
68,528
68,574
68,762
68,890
68,996
69,104
69,10468,99668,89068,76268,57468,52868,30768,07067,81048,05945,095-9,098-9,132-9,15600-9,2700



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue9,928
Cost of Revenue-6,886
Gross Profit3,0423,042
 
Operating Income (+$)
Gross Profit3,042
Operating Expense-14,212
Operating Income-11,169-11,169
 
Operating Expense (+$)
Research Development4,597
Selling General Administrative7,724
Selling And Marketing Expenses3,956
Operating Expense14,21216,277
 
Net Interest Income (+$)
Interest Income340
Interest Expense-16
Other Finance Cost-215
Net Interest Income109
 
Pretax Income (+$)
Operating Income-11,169
Net Interest Income109
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-11,099-11,239
EBIT - interestExpense = -11,185
-11,099
-11,083
Interest Expense16
Earnings Before Interest and Taxes (EBIT)-11,169-11,083
Earnings Before Interest and Taxes (EBITDA)-9,104
 
After tax Income (+$)
Income Before Tax-11,099
Tax Provision-0
Net Income From Continuing Ops-11,099-11,099
Net Income-11,099
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses21,098
Total Other Income/Expenses Net70-109
 

Technical Analysis of Ispecimen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ispecimen. The general trend of Ispecimen is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ispecimen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of iSpecimen Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.4 < 0.407 < 0.4151.

The bearish price targets are: 0.201 > 0.2.

Tweet this
iSpecimen Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of iSpecimen Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

iSpecimen Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of iSpecimen Inc.

iSpecimen Inc Daily Moving Average Convergence/Divergence (MACD) ChartiSpecimen Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of iSpecimen Inc. The current adx is .

iSpecimen Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of iSpecimen Inc.

iSpecimen Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of iSpecimen Inc.

iSpecimen Inc Daily Relative Strength Index (RSI) ChartiSpecimen Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of iSpecimen Inc.

iSpecimen Inc Daily Stochastic Oscillator ChartiSpecimen Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of iSpecimen Inc.

iSpecimen Inc Daily Commodity Channel Index (CCI) ChartiSpecimen Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of iSpecimen Inc.

iSpecimen Inc Daily Chande Momentum Oscillator (CMO) ChartiSpecimen Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of iSpecimen Inc.

iSpecimen Inc Daily Williams %R ChartiSpecimen Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of iSpecimen Inc.

iSpecimen Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of iSpecimen Inc.

iSpecimen Inc Daily Average True Range (ATR) ChartiSpecimen Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of iSpecimen Inc.

iSpecimen Inc Daily On-Balance Volume (OBV) ChartiSpecimen Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of iSpecimen Inc.

iSpecimen Inc Daily Money Flow Index (MFI) ChartiSpecimen Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for iSpecimen Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-28MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

iSpecimen Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of iSpecimen Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.290
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ispecimen with someone you think should read this too:
  • Are you bullish or bearish on Ispecimen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ispecimen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about iSpecimen Inc

I send you an email if I find something interesting about iSpecimen Inc.


Comments

How you think about this?

Leave a comment

Stay informed about iSpecimen Inc.

Receive notifications about iSpecimen Inc in your mailbox!